comprehensive -WSS

comprehensive

author：focus 2025-09-28 01:37:48 - browse：72315

Today, if you want to know what scary family health secrets lay buried in your DNA or get screened for a lurking cancer, you have a lot of options. Laboratories have developed more than 75,000 genetic tests, with about 10 new ones entering the market daily. By the end of 2019, more than 26 million Americans had had their DNA decoded to some degree or another. Since then, that number has surely grown.

But this testing frenzy would have been inconceivable just 10 years ago. In part, that’s because the technology back then was so expensive. More importantly, until 2013, it was common practice for gene-hunting academics and companies to lock up their discoveries with DNA patents, effectively carving up the human genome into mini-monopolies. That year, the U.S. Supreme Court threw a bomb into the biotech world when it took up a landmark case that pitted cancer survivors and the American Civil Liberties Union against a diagnostics company called Myriad Genetics, which had obtained exclusive patents on the cancer-causing BRCA genes and made billions of dollars selling tests for them.

A new book called “The Genome Defense,” written by University of Utah science and technology law expert Jorge Contreras and being published Oct. 26, provides a front-row seat to the courtroom drama that would upend three decades of federal intellectual property law and chart a new course toward balancing corporate profits with the rights of all people to the information written into their DNA.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Involuntary treatment for addiction doesn't work

focus

WSS

How CRISPR works, explained in two minutes

Congress likely to miss an opportunity to fix drug shortages issue

Doctors push to include dialysis machines in emergency stockpile

Everything to know for the next Powerball drawing as jackpot hits $1 billion

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

With heat waves through August, officials warn of health risks

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Cancer drug shortages should be causing more outrage

Pennsylvania man bitten on the head by bear during attack in his garage

As demand for Covid shots wanes, Moderna seeks its next success

Sweden knocks USA out of World Cup in penalty kicks

BioMarin wins approval for gene therapy to treat hemophilia A

J&J expands global access to TB drug amid advocacy campaign

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Cancer drug shortages should be causing more outrage

Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

focus

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Congress likely to miss an opportunity to fix drug shortages issue

With heat waves through August, officials warn of health risks

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Mike Pence clashes with Tucker Carlson in Iowa

'Brian's Song' at 50 still offers lessons about cancer for today

explore

focus

focus

hotspot